Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01846130 · ClinicalTrials.gov registry record · NA
Preserving Muscle Mass and Function in Bedridden Older Adults
A NA study of Bed Rest, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 1
- Study location
NCT01846130: Completed NA study of Bed Rest, sponsored by The University of Texas Medical Branch, Galveston.
NCT01846130 is a NA study of Bed Rest that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 123 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01846130, a NA study of Bed Rest, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose that low-intensity exercise and supplementing daily meals with leucine or whey will independently and synergistically reduce the deleterious effects of inactivity on skeletal muscle and facilitate recovery during rehabilitation.
Primary Outcome
The lower body musculature is primarily affected by physical inactivity (19). Lean leg mass will be determined by segmental dual energy x-ray absorptiometry (iDXA:General Electric, Lunar, Madison, WI). The whole body scan will be divided in sub-regions for analysis.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- DIETARY_SUPPLEMENT Whey protein
- DIETARY_SUPPLEMENT Leucine
Study Locations (1)
Texas
- Unversity of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT01846130 record still lists
NCT01846130 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Bed Rest appearing as the primary indexed condition, and to 3 interventions - of which Exercise is the first listed.
NCT01846130 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01846130 about?
NCT01846130 is a clinical study titled "Preserving Muscle Mass and Function in Bedridden Older Adults". The investigators propose that low-intensity exercise and supplementing daily meals with leucine or whey will independently and synergistically reduce the deleterious effects of inactivity on skeletal muscle and facilitate recovery during rehabilitation.
What is the current status of trial NCT01846130?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2013-01. Estimated completion is 2018-12.
What conditions does trial NCT01846130 study?
This clinical trial studies the following conditions: Bed Rest.
What interventions are being tested in trial NCT01846130?
The interventions under investigation include: Exercise (BEHAVIORAL), Whey protein (DIETARY_SUPPLEMENT), Leucine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01846130?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01846130 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01846130's enrollment target sits among peer trials
123 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia